The FDA record for K261622 lists Philips Consumer Lifestyle B.V. as applicant, with a filing address at Tussendiepen 4, Drachten, Netherlands, and a contact named Jeff Chau. The submission was received May 15, 2026, reviewed under the Obstetrics/Gynecology advisory committee, and decided September 3, 2026 with decision code SESE, described as Substantially Equivalent. It was a Traditional clearance, not a third-party review, and the record notes a Summary rather than a statement. The device name spans four model numbers: SCF593/52 and SCF593/62 for the Natural Care Hands-free Wearable Electric Breast Pump, and SCF594/52 and SCF594/62 for the Natural Care Warming Hands-free Wearable Electric Breast Pump. The filing address is a regulatory correspondence point in the FDA record, not a verified corporate headquarters. [1][2]
What the clearance covers
The FDA record classifies the cleared device as "Pump, Breast, Powered" under product code HGX, device class 2, regulation number 884.5160, with Obstetrics/Gynecology as both the advisory and review committee. The applicant is recorded as Philips Consumer Lifestyle B.V. of the Netherlands, country code NL. The record identifies the submission as a Traditional 510(k) with a Summary available and no expedited review flag. [1]
The FDA's 510(k) Premarket Notification database entry for K261622 is the public lookup page for this clearance; the retrieved page content shows the database navigation framework rather than the full decision detail, so the substantive parameters above rest on the API record. [2]
Documented product identities and components
Philips' published booklet for the SCF593/52 and SCF593/62 identifies the product as a Hands-free Wearable Double Electric Breast Pump and lists breast shield sizes of 15 mm, 17 mm, 19 mm, 21 mm, 24 mm and 27 mm, with flange pairings such as 27 mm to 19 mm, 27 mm to 17 mm, 27 mm to 15 mm and 27 mm to 24 mm. The booklet carries a 2026 copyright notice for Koninklijke Philips N.V. and lists Philips North America LLC in Stamford, Connecticut, and Philips Electronics Ltd. in Mississauga, Ontario, as distribution entities for the United States and Canada respectively. [3]
The United States product page for SCF593/62 describes the Avent Double Electric Breast Pump Natural Care Hands-free Wearable as new and states that it mimics the baby's drinking rhythm. A separate Philips support article frames the Natural Care and Natural Care Warming Wearable Electric Breast Pumps around freedom and flexibility for the user. [4][5]
Philips' hands-free breast pump category page describes the pump as using a quiet, hospital-strength motor, soft silicone breast shields and lightweight collection cups, and states that it mimics the baby's drinking rhythm for effective expression. These are the manufacturer's own product claims, published by Philips, not independent findings. [6]
Launch framing and support material
A Philips press release dated September 1, 2026 announces the launch of the Natural Care Wearable Breast Pump, describing it as discreet, lightweight and worn in-bra, freeing the user's hands and time while pumping. The release states that the pump mimics baby's natural drinking rhythm supporting effective pumping, with an asterisked qualifier in the original. The release is attributed to Philips' corporate news channel and names Patricia Vergeer as Senior Communications Manager Personal Health. [8]
Philips publishes a support article addressing how to set up and use the Natural Care Hands-free Wearable Electric Breast Pump, and a product support page for SCF593/62 that organizes videos, product registration, manuals and documentation, FAQs and troubleshooting. These pages confirm that user-facing support material exists for the model; they do not establish clinical performance. [7][9]
How to read the filing record
The linked collection for this applicant, as of the snapshot date, contains one 510(k) record, and that single record carries a SESE decision. Because the collection and the record sample coincide at one entry, the decision counts and sample decision counts are identical; neither figure describes total company sales, total product portfolio or safety performance. [1]
Philips Consumer Lifestyle B.V. is the applicant of record on K261622. The Avent brand and the Koninklijke Philips N.V. trademark ownership noted in the booklet are separate from the applicant identity; the FDA record does not establish a parent-subsidiary relationship, and the Stamford and Mississauga addresses appear in manufacturer documentation as distribution contacts rather than as the applicant. [1][3]

